Universal Biosensors Inc
Company Profile
Business description
Universal Biosensors Inc is biosensor company in electrochemical cell technology to develop a diverse range of biosensor test strips. The company's platform develops a diverse range of biosensor test strips used in conjunction with point-of-use devices that are used in various industries such as healthcare (point-of-care), wine, food and agriculture. It manufactures and distributes PT-INR coagulation test strips and devices, Xprecia, Stride and Xprecia Prime which are medical devices, Sentia non-medical wine testing products, and Petrackr which is a blood glucose test used in cats and dogs. It has one reportable segment: specialist biosensors company. Geographically, the company generates majority of its revenue from Australia and rest from Americas, Europe and other markets.
Contact
1 Corporate Avenue
RowvilleVIC3178
AUST: +61 392139000
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
76
Stocks News & Analysis
stocks
Chart of the Week: We see opportunity in Mineral Resources despite debt concerns
stocks
The ultimate investing hack: dividend growth stocks
stocks
Is the data centre party over for Goodman?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,886.00 | 30.50 | -0.34% |
| CAC 40 | 8,087.42 | 12.81 | 0.16% |
| DAX 40 | 23,693.71 | 17.15 | -0.07% |
| Dow JONES (US) | 47,882.90 | 408.44 | 0.86% |
| FTSE 100 | 9,692.07 | 9.73 | -0.10% |
| HKSE | 25,718.75 | 41.98 | -0.16% |
| NASDAQ | 23,454.09 | 40.42 | 0.17% |
| Nikkei 225 | 50,526.15 | 661.47 | 1.33% |
| NZX 50 Index | 13,509.78 | 72.76 | -0.54% |
| S&P 500 | 6,849.72 | 20.35 | 0.30% |
| S&P/ASX 200 | 8,594.00 | 24.80 | -0.29% |
| SSE Composite Index | 3,868.25 | 9.75 | -0.25% |